Clinical Trial Update: Study to Assess the Safety of Escalating Doses of AT13387 in Patients With Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1 study evaluating escalating doses of AT13387 (onalespib) in patients with metastatic solid tumors…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• AT13387 (AT13387)

Snippet

Sponsor: Astex Pharmaceuticals, Inc. | Conditions: Metastatic Solid Tumors | Phase 1 | Status: COMPLETED